Cat Chronic Pain Medication Advances

New pharmaceutical options improving quality of life for cats with chronic pain conditions.

Key Facts

Chronic pain affects an estimated 40% of cats over age 10, primarily from osteoarthritis
NSAIDs approved for long-term cat use are limited due to feline liver and kidney sensitivity
Solensia (frunevetmab) is a monoclonal antibody approved for feline OA pain in the EU and US
Gabapentin is widely used off-label for chronic pain management in cats
Buprenorphine is an effective opioid used for moderate to severe pain in cats
Multimodal pain management combining medications, acupuncture, and environmental modification improves outcomes

Welfare Considerations

Chronic pain management in cats has been transformed by the availability of monoclonal antibody treatments that specifically target pain pathways without the metabolic risks of traditional NSAIDs. Cats' unique metabolism makes them vulnerable to toxicity from many pain medications safe in dogs and humans, leaving chronic pain historically undertreated in felines. The development of feline-specific biologics represents a major welfare advance, as does growing awareness that cats commonly suffer from osteoarthritis that owners and even vets often attribute to normal aging rather than a treatable painful condition.

What You Can Do

Schedule a wellness check if your cat shows reduced activity, altered gait, or grooming changes
Discuss Solensia or other chronic pain options with your vet for cats over 10
Never give human or dog NSAIDs to cats - many cause fatal kidney or liver failure
Implement environmental modifications including ramps and low-entry litter boxes alongside medication
Consider complementary therapies including physiotherapy and acupuncture for chronic pain
Monitor body weight monthly as pain-related activity reduction often leads to obesity